Jefferies says Hologic's (HOLX +1.2%) pending acquisition of Gen-Probe (GPRO +0.5%) could be a...


Jefferies says Hologic's (HOLX +1.2%) pending acquisition of Gen-Probe (GPRO +0.5%) could be a significant earnings driver for the combined company. The firm believes the combination could generate $2.68 in EPS including almost $1.00 in incremental earnings by FY15. Jefferies says HOLX is very attractive at current levels and reiterates a Buy on the name with a $24 price target.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs